Norton Rose Fulbright represented Sanctum Therapeutics Corporation in the transaction. Adnexus Biotechnologies Inc. (Adnexus) executed a merger agreement with Sanctum Therapeutics Corporation to acquire Sanctum Therapeutics...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here